Inhaled furosemide prevents ultrasonically nebulized water bronchoconstriction in children with both atopic and nonatopic asthma.
To determine whether inhaled furosemide can modify the bronchoconstriction induced by ultrasonically nebulized distilled water (UNDW) in children with both atopic and nonatopic asthma, a single-blind, randomized, placebo-controlled study was undertaken. The UNDW inhalation challenge was performed in 21 asthmatic children (atopic, 14; nonatopic, 7; mean +/- SEM age, 11.5 +/- 0.5 years), who had a fall in FEV1 of at least 20 percent after distilled water inhalation. On separate days, these subjects underwent UNDW challenge test after inhalation of furosemide (10 mg/body square meters) or placebo (saline solution). Inhaled furosemide exerted a protective effect against bronchoconstriction induced by UNDW in children with both atopic and nonatopic asthma (p < 0.01, p < 0.05, respectively). These results indicate that the protective action of furosemide against UNDW-induced bronchoconstriction may be independent of its direct inhibitory effect on airway mast cell activation.
Shimizu
T
T
Department of Pediatrics, Gunma University School of Medicine, Japan.
Mochizuki
H
H
Morikawa
A
A
Kuroume
T
T
D000280:Administration, Inhalation; D001249:Asthma / Q000150:complications / Q000503:physiopathology*; D001985:Bronchial Provocation Tests; D016084:Bronchoconstriction / Q000187:drug effects; D002648:Child; D005260:Female; D005665:Furosemide / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications*; D008297:Male; D009330:Nebulizers and Vaporizers; D016037:Single-Blind Method; D014465:Ultrasonics; D014867:Water / Q000008:administration & dosage*
D014867:Water; D005665:Furosemide